US 11,883,412 B2
Treatment for cellulitis and pre-operative treatment
Patrick Musitano, Hamilton (CA); and Paul Zalzal, Oakville (CA)
Assigned to Multimode Medical Holdings Inc., Hamilton (CA); and Paul Zalzal, Oakville (CA)
Filed by Multimode Medical Holdings Inc., Hamilton (CA); and Paul Zalzal, Oakville (CA)
Filed on Mar. 18, 2022, as Appl. No. 17/698,214.
Application 17/698,214 is a continuation of application No. 16/729,670, filed on Dec. 30, 2019, granted, now 11,311,550.
Claims priority of provisional application 62/785,758, filed on Dec. 28, 2018.
Prior Publication US 2022/0202825 A1, Jun. 30, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/545 (2006.01); A61K 31/167 (2006.01); A61K 31/192 (2006.01); A61K 9/00 (2006.01)
CPC A61K 31/545 (2013.01) [A61K 9/0014 (2013.01); A61K 31/167 (2013.01); A61K 31/192 (2013.01)] 6 Claims
 
1. A composition for treatment of cellulitis comprising:
by weight: about 85% transdermal cream;
about 5% Cephalexin or Clindamycin;
about 5% Ketoprofen; and
about 5% Lidocaine,
wherein the composition has a density of about 1 gram per milliliter.